Kimberly J Popovits - Net Worth and Insider Trading
Kimberly J Popovits Net Worth
The estimated net worth of Kimberly J Popovits is at least $7 Million dollars as of 2024-09-20. Kimberly J Popovits is the President and CEO of Genomic Health Inc and owns about 116,734 shares of Genomic Health Inc (GHDX) stock worth over $7 Million. Kimberly J Popovits is also the Director of Talis Biomedical Corp and owns about 28,193 shares of Talis Biomedical Corp (TLIS) stock worth over $53,567. Details can be seen in Kimberly J Popovits's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kimberly J Popovits has not made any transactions after 2021-02-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kimberly J Popovits
Kimberly J Popovits Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kimberly J Popovits owns 6 companies in total, including Kiniksa Pharmaceuticals International PLC (KNSA) , MyoKardia Inc (MYOK) , and 10x Genomics Inc (TXG) among others .
Click here to see the complete history of Kimberly J Popovits’s form 4 insider trades.
Insider Ownership Summary of Kimberly J Popovits
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KNSA | Kiniksa Pharmaceuticals International PLC | 2018-05-23 | director |
| MYOK | MyoKardia Inc | 2020-06-18 | director |
| TXG | 10x Genomics Inc | 2020-03-26 | director |
 | | 2015-12-17 | director |
| | 2005-07-15 | director |
| | 2021-02-17 | director |
Kimberly J Popovits Latest Holdings Summary
Kimberly J Popovits currently owns a total of 2 stocks. Among these stocks, Kimberly J Popovits owns 116,734 shares of Genomic Health Inc (GHDX) as of October 8, 2019, with a value of $7 Million and a weighting of 99.28%. Kimberly J Popovits also owns 28,193 shares of Talis Biomedical Corp (TLIS) as of February 17, 2021, with a value of $53,567 and a weighting of 0.72%.
Latest Holdings of Kimberly J Popovits
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GHDX | Genomic Health Inc | 2019-10-08 | 116,734 | 63.44 | 7,405,605 |
| TLIS | Talis Biomedical Corp | 2021-02-17 | 28,193 | 1.90 | 53,567 |
Holding Weightings of Kimberly J Popovits
Kimberly J Popovits Form 4 Trading Tracker
According to the SEC Form 4 filings, Kimberly J Popovits has made a total of 1 transactions in Genomic Health Inc (GHDX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Genomic Health Inc is the sale of 10,000 shares on October 8, 2019, which brought Kimberly J Popovits around $677,400.
According to the SEC Form 4 filings, Kimberly J Popovits has made a total of 1 transactions in Talis Biomedical Corp (TLIS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Talis Biomedical Corp is the acquisition of 353 shares on February 17, 2021, which cost Kimberly J Popovits around $84,800.
Insider Trading History of Kimberly J Popovits
- 1
Kimberly J Popovits Trading Performance
GuruFocus tracks the stock performance after each of Kimberly J Popovits's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kimberly J Popovits is -57.91%. GuruFocus also compares Kimberly J Popovits's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kimberly J Popovits within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kimberly J Popovits's insider trading performs compared to the benchmark.
Performance of Kimberly J Popovits
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -31.39 | | | | | |
| Relative Return to S&P 500(%) | -32.48 | | | | | |
Kimberly J Popovits Ownership Network
Kimberly J Popovits Owned Company Details
What does Kiniksa Pharmaceuticals International PLC do?
Who are the key executives at Kiniksa Pharmaceuticals International PLC?
Kimberly J Popovits is the director of Kiniksa Pharmaceuticals International PLC. Other key executives at Kiniksa Pharmaceuticals International PLC include Group VP & Rilonacept GM Ross Moat , Chief Medical Officer John Paolini , and Chief Business Officer Eben Tessari .
Kiniksa Pharmaceuticals International PLC (KNSA) Insider Trades Summary
Over the past 18 months, Kimberly J Popovits made no insider transaction in Kiniksa Pharmaceuticals International PLC (KNSA). Other recent insider transactions involving Kiniksa Pharmaceuticals International PLC (KNSA) include a net sale of 150,848 shares made by John Paolini , a net sale of 219,460 shares made by Sanj K Patel , and a net sale of 24,101 shares made by Michael R Megna .
In summary, during the past 3 months, insiders sold 329,070 shares of Kiniksa Pharmaceuticals International PLC (KNSA) in total and bought 0 shares, with a net sale of 329,070 shares. During the past 18 months, 504,663 shares of Kiniksa Pharmaceuticals International PLC (KNSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 504,663 shares.
Kiniksa Pharmaceuticals International PLC (KNSA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kiniksa Pharmaceuticals International PLC Insider Transactions
Kimberly J Popovits Mailing Address
Above is the net worth, insider trading, and ownership report for Kimberly J Popovits. You might contact Kimberly J Popovits via mailing address: 301 Penobscot Drive, Redwood City Ca 94063.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
